Navigation Links
Dow AgroSciences' Success Presented to Wall Street
Date:2/12/2008

Company Outlines Ambitious Growth Plans, Technology Leadership

INDIANAPOLIS, Feb. 12 /PRNewswire-FirstCall/ -- The growing technology share of Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), was the focus of a presentation made to investors earlier today by Jerome Peribere, president and CEO of Dow AgroSciences. Peribere was speaking at the Goldman Sachs Agricultural Chemicals Conference in New York City, where he reinforced Dow AgroSciences' technology-based strategy of growing its agricultural chemicals business while developing new biotechnology products and platforms.

"We believe the company with the best technology will ultimately generate the most value," said Peribere. "We are building our capabilities to do exactly that and provide our customers with revolutionary solutions."

He cited numerous examples of the Company's innovation -- from both the chemical and biological sides of the portfolio -- and highlighted the progress of the seeds business during 2007, including growth in the Americas for its corn, cotton, sunflower, and canola product portfolios.

A key move in 2007 was the Company's announcement of its SmartStax(TM) agreement with Monsanto, creating the industry's first eight-gene stack of traits in corn. As a result of this scientific breakthrough, Peribere expects Dow's HERCULEX(TM) insect protection technology to be on approximately 40 percent of U.S. corn acres in the SmartStax launch year of 2010 and on about 60 percent of acres by 2012. This technology package will be further enhanced when Dow AgroSciences launches its Dow Herbicide Tolerance technology in 2012 for corn, and in 2013 for cotton and soybeans.

Peribere concluded that growth for Dow
'/>"/>

SOURCE The Dow Chemical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
4. EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme
5. Life on Mars pregnancy test successfully launched
6. Of mice and men: new male contraceptives successful in rodents and humans
7. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
8. AMDL to Present its China Success Story at Rodman & Renshaw 9th Annual Healthcare Conference
9. Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries
10. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
11. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... and NEW YORK ... (NASDAQ: PTBI ), a biopharmaceutical company advancing ... announced today that its Korean marketing partner, Hanmi ... marketing approval in Korea from the country,s Ministry ... Korea Testing & Research Institute (KTR) for MuGard, ...
(Date:3/31/2015)... 31, 2015 This June 13th, a ... top U.S and International Medical Schools will come together ... on the application of stem cell therapy in treatments ... organized and funded by the Ocular Research Symposia ... been convening intimate meetings of top experts in the ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Diasome Pharmaceuticals, ... licensor, SDG, Inc., that a United States patent has ... insulin therapy. , Entitled “Lipid Construct for ... composition of matter claims related to the use of ... for enabling injected insulin to more effectively reach the ...
(Date:3/30/2015)... With recent advancements in residential solar ... major companies are getting into the Solar Energy wave. ... for renewable energy production, many homeowners are looking to ... is a new solar distribution company in California which ... qualifying homeowners to enjoy the benefits of solar energy ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2Solara Power Announces Residential Solar Power with No Up-Front Fees 2
... Israel and JERSEY CITY, New Jersey, July 3, Rosetta ... microRNA-based diagnostics and therapeutics, announced today,it will present Collins ... 8:30 am EST at the Mandarin Oriental Hotel in ... ROSG ) is a leader in the field ...
... 3 AMDL, Inc. (Amex:,ADL), a world leader ... in Shenzhen, Jiangxi, and Jilin, China, announced,today it ... for,viewing on the Company,s website at http://www.amdl.com ... a global specialty pharmaceutical company. The company is,headquartered ...
... 2 Effective immediately, SpectraCell,Laboratories now measures ... proprietary FIA(TM) (Functional Intracellular Analysis) technology.,This test ... and mineral,deficiencies long before classic deficiency symptoms ... in patients has been climbing in recent ...
Cached Biology Technology:AMDL Announces Investor Relations Presentation Available on Website 2SpectraCell Laboratories Now Measures Vitamin C 2
(Date:3/24/2015)... --  NexID Biometrics LLC, whose spoof-mitigation technology boosts ... the beginning of shipments of version 2.0 of its ... based in Potsdam, N.Y. , is ... began here today at the Walter E. Washington Convention ... SDK boosts the accuracy rate range to 96.5 to ...
(Date:3/23/2015)... Conn. , Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... new advertising campaign on CNBC television starting March 30 th ... will commence airing in New York ... Officer said: "We are excited about our new ad campaign ...
(Date:3/19/2015)... March 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, announces its biometric payment ... clip that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host ... way to pay, and ,a really big breakthrough in mobile ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... The humble papaya is gaining credibility in Western medicine ... generations. University of Florida researcher Nam Dang, M.D., ... anticancer effect against a broad range of lab-grown tumors, ... pancreas. The researchers used an extract made from dried ...
... Technical Research Centre of Finland will establish a Centre of ... the water sector is being gathered into one centre. The ... the water sector in Finland and to create new business ... research centre will be known as the Centre of Water ...
... - For decades, the traditional practice in animal testing ... has shown that adding as few as two controlled ... costly false positives, the number of animals needed for ... Joseph Garner, a Purdue assistant professor of animal sciences, ...
Cached Biology News:Papaya extract thwarts growth of cancer cells in lab tests 2Finland to get a Center of Water Efficiency Excellence 2Intentional variation increases result validity in mouse testing 2Intentional variation increases result validity in mouse testing 3
Gloves are 9.25 long, latex, powder free, smooth and ambidextrous....
Request Info...
Prepared with distilled water. Yeast extract solution is autolyzed at 150 g/L....
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
Biology Products: